我要投票 香雪XPH在医疗器械行业中的票数:587
· 外 推 电 报 ·
2025-11-23 05:28:03 星期日

【香雪XPH是哪个国家的品牌?】

香雪XPH是什么牌子?「香雪XPH」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人王董在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪XPH品牌出海!将品牌入驻外推网,定制香雪XPH品牌推广信息,可以显著提高香雪XPH产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

广州市香雪制药股份有限公司,始于1986年,广东省名牌,药典标准制定者,大中药健康产业领先者,现代化高新技术医药企业


“十里梅花浑似雪,萝岗香雪映朝阳。”诗人郭沫若赋诗赞赏的羊城八景之一“萝岗香雪”, 正是香雪制药的发祥地。1986年萝岗制药厂成立,1997年改制为广州市香雪制药股份有限公司,于2010年在中国深圳证券交易所公开发行股票(IPO)挂牌上市(股票代码:300147)。秉承“厚生、臻善、维新”的经营理念,公司把发展中药和实现中药现代化作为长远发展战略,经多年发展,现已成为拥有自主知识产权、自主品牌、自主创新能力的中药现代化的领军企业和技术企业,形成中药资源开发、中药先进制造、现代物流配送、新药创制的完整产业链。香雪制药先后在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司并投资兴建大规模的GMP生产基地和GAP药材种植基地,形成了新型中药饮片、中成药、功能健康食品(饮料)、养生保健等产品群所组成的大中药健康产业,在中国创造就业职位一万余个。

数字化中药

香雪制药致力于中药现代化的研究和实践,在中药现代化的关键技术——中成药质量控制技术、现代制剂技术、中药给药途径创新等研究取得丰硕成果及突破。香雪制药建立了以“现代中药指纹图谱质量控制技术”为核心的现代中药集成创新系统,应用指纹图谱质控技术,通过计算机相似度分析系统使得成分复杂的中药质量得到有效控制;应用中药临床循证医学评价方法,通过大样品、多中心的大规模临床数据评价使中药疗效准确与经济。香雪制药引进全球先进的信息管理系统,使中药生产经营、销售服务过程实现全面信息资源管理,对企业资源、供应链、客户关系、节能环保、智能办公等方面完成高度集成,使中药企业管理与大数据时代接轨。


英文翻译:Guangzhou Xiangxue Pharmaceutical Co., Ltd. started in 1986. It is a famous brand in Guangdong Province, a standard maker of Pharmacopoeia, a leader in the health industry of traditional Chinese medicine, and a modern high-tech pharmaceutical enterprise Luogang Xiangxue, one of the eight sceneries in Yangcheng, is the birthplace of Xiangxue pharmaceutical. Luogang pharmaceutical factory was established in 1986, and was restructured into Guangzhou Xiangxue Pharmaceutical Co., Ltd. in 1997. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300147). Adhering to the business philosophy of "health, perfection and renovation", the company takes the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as its long-term development strategy. After years of development, the company has become a leading enterprise and technical enterprise with independent intellectual property rights, independent brand and independent innovation ability, forming the development of traditional Chinese medicine resources, advanced manufacturing of traditional Chinese medicine, modern logistics and distribution, and the creation of new drugs A complete industrial chain. Xiangxue pharmaceutical has successively set up 18 companies in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia and invested in the construction of large-scale GMP production base and gap medicine planting base, forming a large traditional Chinese medicine health industry composed of new traditional Chinese medicine pieces, proprietary Chinese medicine, functional health food (beverage), health care and other product groups, creating jobs in China More than 10000. Xiangxue pharmaceutical is committed to the research and practice of the modernization of traditional Chinese medicine, and has made fruitful achievements and breakthroughs in the key technologies of the modernization of traditional Chinese medicine, such as the quality control technology of traditional Chinese medicine, the modern preparation technology, and the innovation of the way of administration of traditional Chinese Medicine. Xiangxue pharmaceutical has established a modern integrated innovation system of traditional Chinese medicine with "modern fingerprint quality control technology" as the core. By using fingerprint quality control technology and computer similarity analysis system, the quality of traditional Chinese medicine with complex components can be effectively controlled. By using the clinical evidence-based medicine evaluation method of traditional Chinese medicine, the quality of traditional Chinese medicine can be effectively controlled through large-scale clinical data evaluation of large samples and multi centers The therapeutic effect is accurate and economical. Xiangxue pharmaceutical introduced the world's advanced information management system to realize the comprehensive information resource management in the process of Chinese medicine production, operation and sales service, and highly integrated the enterprise resources, supply chain, customer relationship, energy conservation and environmental protection, intelligent office, etc., so as to make the Chinese medicine enterprise management in line with the big data era.

本文链接: https://www.waitui.com/brand/5a03ebbad.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

《大型网络平台个人信息保护规定(征求意见稿)》公开征求意见

36氪获悉,国家互联网信息办公室、公安部就《大型网络平台个人信息保护规定(征求意见稿)》公开征求意见。征求意见稿提出,大型网络平台服务提供者应当将在中华人民共和国境内运营中收集和产生的个人信息存储在境内。确需向境外提供的,应当符合国家数据出境安全管理有关规定。大型网络平台服务提供者应当按照国家有关规定,健全个人信息出境安全相关技术和管理措施,及时防范、处置个人信息违法违规出境安全风险和威胁。

2小时前

宁德时代与上汽商用车达成深度战略合作

36氪获悉,11月22日,据宁德时代微信公众号,在第21届广州国际车展上,宁德时代与上汽商用车正式宣布达成深度战略合作。双方将围绕“技术共研、生态共建、全球共进”三大方向,在商用车新能源化、智能化领域全面深化合作,共同构建“车、电、站、云”一体化的智慧换电生态与绿色运力体系。

2小时前

北京“十四五”期间企业直接融资超5.6万亿元

据新华社,记者从日前举行的首都“十四五”规划高质量收官系列主题新闻发布会金融业发展成就专场上获悉,“十四五”期间,北京地区多元化融资渠道进一步拓宽,企业实现直接融资超5.6万亿元。金融“五篇大文章”合计贷款余额6.8万亿元,高于人民币各项贷款增速2.1个百分点,为首都经济持续向好和高质量发展营造良好的金融环境。(新华网)

2小时前

李斌:乐道也将有右舵车型

36氪获悉,11月21日,蔚来创始人李斌表示:乐道接下来也会有右舵车型,它需要时间。 今年11月18日,蔚来旗下高端小车品牌萤火虫的右舵车型正式量产,首批将发运至新加坡市场。未来,乐道也将推出右舵车型。

2小时前

鸭绒价格近期仍在高位 中下游追单采购意愿活跃

财联社记者从业内了解到,羽绒服目前进入消费旺季,“(白鸭绒价)10月份几乎是一天一个价,这段时间没有在涨,维持在高位。”尽管多数企业认为当前的原料价格偏高,但由于前期备货不足,促使中下游的追单采购意愿保持活跃。上市公司方面,记者采访获悉华英农业羽绒加工产能满产;古麒绒材当前整体羽绒产能2288吨,公司具备一定数量的鸭绒和鹅绒库存,随着羽绒价格上涨,公司库存相应增值。(财联社)

2小时前

本页详细列出关于香雪XPH的品牌信息,含品牌所属公司介绍,香雪XPH所处行业的品牌地位及优势。
咨询